By Dr Andrew On Wah Yam

Conference Abstracts

Joshua AM; Talmor B; Crumbaker M; Yam AO; Ng CA; Luckett T, 2026, 'Determining individual preferences for gynecomastia avoidance among men with prostate cancer: A qualitative study.', in Journal of Clinical Oncology, Vol. 44, pp. TPS407 - TPS407, http://dx.doi.org/10.1200/JCO.2026.44.7_suppl.TPS407

Pathmanandavel S; Crumbaker M; Yam AO; Nguyen A; Niman R; Wilson P; Sharma S; Ayers M; Eu P; Stockler MR; Martin AJ; Joshua AM; Emmett L, 2022, 'Quantifying molecular imaging patterns of treatment response or progression using a novel traffic light workflow within a prospective phase I/II trial of 177LuPSMA-617 and NOX66 (LuPIN).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 40, pp. 166 - 166, http://dx.doi.org/10.1200/jco.2022.40.6_suppl.166

Lau B; Crumbaker M; Yam AOW; Marastoni S; Luckhurst M; O'Grady A; Wouters B; Joshua AM, 2021, 'A phase I/II study of hydroxychloroquine and suba-itraconazole in men with biochemical relapse of prostate cancer (HITMAN-PC): Dose escalation results.', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 39, pp. 114 - 114, http://dx.doi.org/10.1200/jco.2021.39.6_suppl.114

Pathmanandavel S; Crumbaker M; Yam AOW; Rofe C; Ho B; Chan WL; Sharma S; Hickey AJ; Kongrak K; Ratnayake L; Kwan EM; Azad A; Eu P; Nguyen A; Joshua AM; Emmett L, 2021, 'Final results of a phase I/II prospective dose escalation trial evaluating safety and efficacy of combination 177Lu PSMA 617 and NOX66 in men with end-stage metastatic castration-resistant prostate cancer (LuPIN trial).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 39, pp. 103 - 103, http://dx.doi.org/10.1200/jco.2021.39.6_suppl.103

Back to profile page